YIMDI
Live / Allowed — First extension granted (statement of use) (as of 25 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99345781
- Mark type
- Word mark
- Filed
- 19 Aug 2025
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders
Owner
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
Prosecution history
- 26 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2026 — SOU EXTENSION 1 GRANTED
- 25 Sept 2026 — SOU EXTENSION 1 FILED
- 25 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2026 — ASSIGNED TO EXAMINER